Avstera Therapeutics has filed a notice of an exempt offering of securities to raise $5,000,000.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Avstera Therapeutics is raising $5,000,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Karthik Musunuri played a key role…